SHALESE AYCOCK: Open Payments
NPI 1386331734 · VALDOSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,176 in 51 payments from 21 companies in 2025. Trend: 2023 $173 · 2024 $809 · 2025 $1,176
Food & beverage: $1,176
| Company | Payments | Amount |
|---|---|---|
| Antares Pharma, Inc. | 9 | $212 |
| UROGEN PHARMA, INC. | 7 | $186 |
| Sumitomo Pharma America, Inc. | 6 | $129 |
| Boston Scientific Corporation | 3 | $99 |
| PFIZER INC. | 3 | $63 |
| Myriad Genetic Laboratories, Inc. | 3 | $58 |
| TOLMAR, INC. | 2 | $53 |
| Endo USA, Inc. | 2 | $52 |
| Procept Biorobotics Corporation | 1 | $38 |
| Ferring Pharmaceuticals Inc. | 2 | $35 |
Products named: XYOSTED, JELMYTO, ORGOVYX, Axonics, XTANDI, PROLARIS, JATENZO, XIAFLEX.
Industry payments across GA — which companies pay providers there.
